{"id":"https://openalex.org/W33406674","doi":null,"title":"Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice.","display_name":"Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice.","publication_year":1997,"publication_date":"1997-07-01","ids":{"openalex":"https://openalex.org/W33406674","mag":"33406674","pmid":"https://pubmed.ncbi.nlm.nih.gov/9385589"},"language":"en","primary_location":{"id":"pmid:9385589","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9385589","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Methods and findings in experimental and clinical pharmacology","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002821906","display_name":"Doodipala Samba Reddy","orcid":"https://orcid.org/0000-0003-2735-9550","observed_orcids":["https://orcid.org/0000-0003-2735-9550"]},"institutions":[{"id":"https://openalex.org/I51452335","display_name":"Panjab University","ror":"https://ror.org/04p2sbk06","country_code":"IN","type":"education","lineage":["https://openalex.org/I51452335"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"D S Reddy","raw_affiliation_strings":["Department of Pharmacology, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India","institution_ids":["https://openalex.org/I51452335"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062309116","display_name":"S.K. Kulkarni","orcid":"https://orcid.org/0000-0002-4480-0830","observed_orcids":["https://orcid.org/0000-0002-4480-0830"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S K Kulkarni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.98,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.85988242,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"19","issue":"6","first_page":"395","last_page":"405"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neurosteroids","display_name":"neurosteroids","score":0.9369999766349792},{"id":"https://openalex.org/keywords/benzodiazepine-tolerance","display_name":"benzodiazepine tolerance","score":0.972000002861023},{"id":"https://openalex.org/keywords/benzodiazepine-withdrawal","display_name":"benzodiazepine withdrawal","score":0.9520000219345093},{"id":"https://openalex.org/keywords/hyperactivity","display_name":"hyperactivity","score":0.878000020980835},{"id":"https://openalex.org/keywords/gaba-a-receptor","display_name":"GABAA receptor","score":0.8500000238418579},{"id":"https://openalex.org/keywords/progesterone","display_name":"progesterone","score":0.6880000233650208},{"id":"https://openalex.org/keywords/allopregnanolone","display_name":"allopregnanolone","score":0.9509999752044678},{"id":"https://openalex.org/keywords/pregnenolone-sulfate","display_name":"pregnenolone sulfate","score":0.9959999918937683},{"id":"https://openalex.org/keywords/triazolam","display_name":"triazolam","score":0.847000002861023},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":0.9599999785423279},{"id":"https://openalex.org/keywords/flumazenil","display_name":"flumazenil","score":0.8679999709129333},{"id":"https://openalex.org/keywords/pk11195","display_name":"PK11195","score":0.9559999704360962},{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":0.8370000123977661},{"id":"https://openalex.org/keywords/cortisol","display_name":"cortisol","score":0.8550000190734863},{"id":"https://openalex.org/keywords/co-administration","display_name":"co-administration","score":0.4410000145435333},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.3659999966621399}],"concepts":[{"id":"https://openalex.org/C44796713","wikidata":"https://www.wikidata.org/wiki/Q2659374","display_name":"Neuroactive steroid","level":4,"score":0.9705716967582703},{"id":"https://openalex.org/C2780957381","wikidata":"https://www.wikidata.org/wiki/Q7239912","display_name":"Pregnenolone sulfate","level":5,"score":0.8768305778503418},{"id":"https://openalex.org/C2778338918","wikidata":"https://www.wikidata.org/wiki/Q2482223","display_name":"Allopregnanolone","level":5,"score":0.7691822052001953},{"id":"https://openalex.org/C173586616","wikidata":"https://www.wikidata.org/wiki/Q5359685","display_name":"Elevated plus maze","level":3,"score":0.7015712857246399},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.6954220533370972},{"id":"https://openalex.org/C2776801781","wikidata":"https://www.wikidata.org/wiki/Q18344323","display_name":"Pregnanolone","level":5,"score":0.6599339842796326},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.6519019603729248},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.6495790481567383},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6423181295394897},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.6245259046554565},{"id":"https://openalex.org/C2778409475","wikidata":"https://www.wikidata.org/wiki/Q421920","display_name":"Flumazenil","level":4,"score":0.6232147216796875},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.44379276037216187},{"id":"https://openalex.org/C2779738154","wikidata":"https://www.wikidata.org/wiki/Q412143","display_name":"Triazolam","level":4,"score":0.4297766387462616},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42562761902809143},{"id":"https://openalex.org/C2780193516","wikidata":"https://www.wikidata.org/wiki/Q412158","display_name":"Pregnenolone","level":4,"score":0.4148326516151428},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41271576285362244},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26285791397094727},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2368437647819519},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.17096221446990967},{"id":"https://openalex.org/C2780902042","wikidata":"https://www.wikidata.org/wiki/Q177911","display_name":"Steroid","level":3,"score":0.07335242629051208},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001570","descriptor_name":"Benzodiazepinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003292","descriptor_name":"Convulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011374","descriptor_name":"Progesterone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011374","descriptor_name":"Progesterone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014229","descriptor_name":"Triazolam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018757","descriptor_name":"GABA Modulators","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9385589","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9385589","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Methods and findings in experimental and clinical pharmacology","raw_type":"Comparative Study"},{"id":"mag:33406674","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9385589","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7993710066","display_name":"NIMH CHEMICAL SYNTHESIS PROGRAM","funder_award_id":"n01mh030003-014","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W222006012","https://openalex.org/W1536585711","https://openalex.org/W1538260185","https://openalex.org/W1847168837","https://openalex.org/W1974386770","https://openalex.org/W1991346214","https://openalex.org/W2010980945","https://openalex.org/W2030398704","https://openalex.org/W2036585172","https://openalex.org/W2051876980","https://openalex.org/W2052106069","https://openalex.org/W2055864845","https://openalex.org/W2067195259","https://openalex.org/W2079134736","https://openalex.org/W2083199038","https://openalex.org/W2087988046","https://openalex.org/W2122386753","https://openalex.org/W2124778667","https://openalex.org/W2130637057","https://openalex.org/W2142919822","https://openalex.org/W2144959737","https://openalex.org/W2171216596","https://openalex.org/W2219363513","https://openalex.org/W2290277226","https://openalex.org/W2314264904","https://openalex.org/W2423252051","https://openalex.org/W2486429029","https://openalex.org/W2532034722","https://openalex.org/W2553498778","https://openalex.org/W2584621797","https://openalex.org/W2595321304","https://openalex.org/W2600002013","https://openalex.org/W2606901861","https://openalex.org/W2755438666","https://openalex.org/W2765939096","https://openalex.org/W2766437176","https://openalex.org/W2883951072","https://openalex.org/W2891597364","https://openalex.org/W2899867564","https://openalex.org/W2900382076","https://openalex.org/W2919054694","https://openalex.org/W2928249199","https://openalex.org/W2942285388","https://openalex.org/W2950427619","https://openalex.org/W2968375503","https://openalex.org/W2968949810","https://openalex.org/W2979101903","https://openalex.org/W3036283888","https://openalex.org/W3043837784","https://openalex.org/W3045316129","https://openalex.org/W3111639297","https://openalex.org/W4236513582","https://openalex.org/W6728451393"],"related_works":["https://openalex.org/W2048616710","https://openalex.org/W2075703978","https://openalex.org/W1978087801","https://openalex.org/W4248603698","https://openalex.org/W4088888","https://openalex.org/W1910892035","https://openalex.org/W2268771058","https://openalex.org/W2011430874","https://openalex.org/W1980178286","https://openalex.org/W1974105549"],"abstract_inverted_index":{"Neurosteroids":[0],"are":[1],"potent":[2],"and":[3,38,43,82,87,93,129,137,171,191,195,211,242,266,282,288,301,303,314],"specific":[4],"modulators":[5],"of":[6,27,36,50,72,99,110,127,166,189,219,240,261,285,296,310,326,331],"the":[7,12,20,25,34,125,132,187,215,238,244,259,280,308,316],"GABAA":[8,73],"receptors":[9],"which":[10],"regulate":[11],"neuronal":[13],"activity":[14],"through":[15],"diverse":[16],"neurotransmitter":[17],"mechanisms.":[18],"In":[19],"present":[21],"study":[22],"we":[23],"investigated":[24],"effects":[26,84,155,206,260],"concomitant":[28],"treatment":[29,49],"with":[30,52,250],"various":[31],"neurosteroids":[32,297,327],"on":[33,80,85,156,162,263],"development":[35,126,188,239,309],"tolerance":[37,76,128,190,241,265,287,311],"recovery":[39,133,267,317],"from":[40,134,268,318],"withdrawal":[41,91,246,289],"anxiety":[42,92,136,194],"hyperactivity":[44,94],"to":[45,77,139,198,312],"chronic":[46,269,319],"benzodiazepines.":[47,320],"Long-term":[48],"mice":[51],"full":[53],"allosteric":[54,64],"modulator":[55,65],"(triazolam":[56],"0.25":[57],"mg/kg/day":[58,68],"for":[59,69,144],"8":[60],"days)":[61,71],"or":[62,158,174,232],"selective":[63],"(diazepam":[66],"20":[67],"21":[70,145],"receptor":[74,121],"induced":[75],"behavioral":[78,205],"sedation":[79],"actimeter":[81,157],"anxiolytic":[83],"plus-maze,":[86],"produced":[88,151],"a":[89,107,115,254,275],"marked":[90],"syndrome":[95],"upon":[96],"abrupt":[97],"cessation":[98],"treatment,":[100],"respectively.":[101],"Concomitant":[102],"progesterone":[103,148,223],"(10":[104,224],"mg/kg,":[105,113],"s.c.),":[106],"neurosteroid":[108,167],"precursor,":[109],"4'-chlordiazepam":[111,150,226,262,306],"(0.25":[112,170,227],"i.p.),":[114],"mitochondrial":[116],"diazepam":[117],"binding":[118],"inhibitor":[119],"(DBI)":[120],"(MDR)":[122],"ligand,":[123],"prevented":[124,237],"significantly":[130],"augmented":[131],"withdrawal-induced":[135,193],"hyperlocomotion":[138,196],"diazepam.":[140],"When":[141,271],"administered":[142],"alone":[143],"days,":[146],"neither":[147],"nor":[149],"any":[152,202],"per":[153,203],"se":[154,204],"plus-maze":[159],"when":[160,207],"tested":[161,208],"post-withdrawal":[163],"days.":[164],"Coadministration":[165,218],"allopregnanolone":[168],"(AP)":[169],"0.5":[172],"mg/kg),":[173,179,185,222,225,228,253],"pregnenolone":[175,299],"sulfate":[176,183,300],"(PS)":[177],"(2":[178,184,234,252],"but":[180],"not":[181],"dehydroepiandrosterone":[182],"abolished":[186],"attenuated":[192],"due":[197],"triazolam,":[199],"without":[200],"producing":[201],"at":[209],"1":[210],"2":[212],"days":[213],"after":[214],"last":[216],"injection.":[217],"flumazenil":[220],"(5":[221],"hydrocortisone":[229],"(100":[230],"mg/kg)":[231,235],"nifedipine":[233],"also":[236],"suppressed":[243],"triazolam":[245,264,286],"syndrome.":[247],"However,":[248],"pretreatment":[249],"PK11195":[251],"MDR":[255,304],"partial":[256],"antagonist,":[257,278],"reversed":[258],"triazolam.":[270],"injected":[272],"simultaneously,":[273],"nifedipine,":[274],"Ca2+":[276],"channel":[277],"potentiated":[279],"progesterone-":[281],"4'-chlordiazepam-induced":[283],"attenuation":[284],"behavior.":[290],"These":[291,321],"findings":[292],"suggest":[293],"that":[294,324],"coadministration":[295,325],"allopregnanolone,":[298],"progesterone,":[302],"ligand":[305],"prevents":[307],"benzodiazepines":[313,332],"augments":[315],"results":[322],"indicate":[323],"may":[328],"facilitate":[329],"discontinuation":[330],"in":[333],"long-term":[334],"therapy.":[335]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}